KLH conjugated synthetic peptide derived from human EGFRvIII. Please contact us for the exact immunogen sequence. The peptide is available as orb374827.
Conjugation:
Unconjugated
Alternative Names:
anti EGFR VIII antibody, anti EGFRviii antibody, anti EGFRv3 antibody, anti EGFRv 3 antibody
EGFRvIII antibody
Clonality:
Polyclonal
Concentration:
- 100 µg (in 200 µl): 0.5 mg/ml- 200 µg (in 400 µl): 0.5 mg/ml
Polyclonal antibodies are purified by peptide affinity chromatography
Form:
10 mM PBS, 0.02% sodium azide
Target:
EGFRvIII
Application Dilute:
WB: 2 µg/ml, IHC-P: 1:200
IHC-P image of human mammary fibroma tissue using EGFRvIII antibody (dilution of primary antibody at 1:200)
Immunohistochemical staining of human mammary fibroma tissue using EGFRvIII antibody (dilution of primary antibody - 1:200)
Immunohistochemical staining of paraffin embedded human endometrial cancer tissue using anti-EGFRvIII (primary antibody at 1:200)
IHC-P staining of human endometrial cancer tissue using EGFRvIII antibody (dilution at 1:200)
Western blot analysis of human breast cancer 3 (lane 1), breast cancer 2 (lane 2), breast cancer 1 (lane 3) using EGFRvIII antibody (Dilution at 2 ug/ml)
WB analysis of human breast cancer tissue using EGFRvIII (dilution of primary antibody - 2 ug/ml)
IHC-P from different cancer patients(Adenocarcinoma).
IHC-P from different cancer patients(Adenocarcinoma).
IHC-P from different cancer patients(Adenocarcinoma).
* VAT and and shipping costs not included. Errors and price changes excepted